AstraZeneca Pharma India Limited (ASTRAZEN) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE203A01020
Key metrics
- Market Cap
- ₹17,351 Cr
- P/E Ratio
- 101.01
- EPS
- 68.71
- Book Value
- 349.12
- P/B Ratio
- 19.67
- ROE
- 21.49%
- ROCE
- 23.86%
- Debt / Equity
- 0.13
- Net Margin
- 8.25%
- Revenue Growth
- 32.64%
- Profit Growth
- 62.02%
- Dividend Yield
- 0.52%
- 52W High
- ₹9,849.50
- 52W Low
- ₹6,835.00
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
- Headquarters
- Bengaluru, India
- Employees
- 600
- Promoter Holding
- 81.48%
The full AstraZeneca Pharma India Limited analysis
Create a free account to open the complete ASTRAZEN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.